Skip to main content
. 2019 Sep 12;12:2885–2897. doi: 10.2147/IDR.S210961

Table 4.

Relationship between ciprofloxacin MIC, point mutations within the QRDRs of DNA gyrase and topoisomerase IV subunit genes and PMQR genes in 114 NAR iNTS isolates

CIP MIC (mg/L) No. of isolates Amino acid change in GyrA Amino acid change in ParC Amino acid change in ParE No. (%) Multiple mutations ratea No. (%) Mutation rateb No. (%) PMQR genes ratec
0-0.125 47 Asp87→Tyr [26], Asp87→Asn [12], Asp87→Gly [5], Ser83→Tyr [4] 47 (100) 25 (53.2)
0.25–0.5 40 Ser83→Tyr[15], Asp87→Gly [8], Asp87→Asn [6], Asp87→Tyr [5], Ser83→Phe [1] Thr57→Ser [24], Ser80→Arg [8], Gly78→Cys [1] 23 (57.5) 40 (100) 29 (72.5)
1–2 21 Ser83→Tyr [14], Asp87→Gly [2], Asp87→Tyr [2], Asp87→Asn [1] Thr57→Ser [19], Gly78→Cys [6], Ser80→Arg [1] 19 (90.5) 19 (90.5) 10 (47.6)
≥4 6 Ser83→Tyr [3], Ser83→Phe [3], Asp87→Asn [3], Asp87→Gly [3] Thr57→Ser [6], Ser80→Arg [3], Ser80→Ile [3] Asp530→Asn [2], Ala538→Thr [3], Ser458→Pro [1] 6 (100) 6 (100) 3 (50)

Notes: Alterations in the QRDRs of gyrB were not found in any of the isolates tested. The a indicates that isolates exhibit at least two mutations in the QRDRs. The b indicates that isolates exhibit one mutation in the QRDRs. The c indicates that isolates exhibit both mutations in the QRDRs and PMQR gene.

Abbreviations: CIP, ciprofloxacin; MIC, minimum inhibitory concentration.